Organization
NIHR UCLH Clinical Research Facility
1 abstract
Abstract
Impact of renal impairment (RI) on pharmacokinetics (PK) and clinical outcomes with mezigdomide plus dexamethasone (DEX) in relapsed/refractory multiple myeloma (RRMM).Org: NIHR UCLH Clinical Research Facility, Department of Clinical Haematology,